Vertex Pharmaceuticals Inc
XETRA:VX1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
V
|
Vertex Pharmaceuticals Inc
XETRA:VX1
|
US |
|
F
|
Federal National Mortgage Association
XMUN:FNM
|
US |
|
V
|
Volvo AB
XMUN:VOL3
|
SE |
Intrinsic Value
The intrinsic value for
Vertex Pharmaceuticals Inc (VX1) under the Base Case is 173.66 EUR.
Compared with the current market price of 227.65 EUR, the stock appears
Overvalued by 24% .
Both DCF and multiples point to overvaluation.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Vertex Pharmaceuticals Inc.
Fundamental Analysis
Revenue & Expenses Breakdown
Vertex Pharmaceuticals Inc
Earnings Waterfall
Vertex Pharmaceuticals Inc
The intrinsic value for
Vertex Pharmaceuticals Inc (VX1) under the Base Case is 173.66 EUR.
Compared with the current market price of 227.65 EUR, the stock appears Overvalued by 24% .